Table 2.

Frequency and duration of side effects among patients treated with escitalopram or duloxetine.

Adverse Event	Frequency							Duration
	Total		Escitalopram		Duloxetine		p-Value	Escitalopram		Duloxetine		p-Value
	(n = 211)		(n = 105)		(n = 106)			(n = 92)		(n = 96)
	n	%	n	%	n	%		Mean (Days)	SD	Mean (days)	SD
Nausea	58	27.5	26	24.8	32	30.2	0.38	7.7	8.5	17.6	36.0	0.20
Headache	53	25.1	27	25.7	26	24.5	0.84	20.8	22.7	12.7	17.4	0.19
Somnolence	48	22.7	23	21.9	25	23.6	0.77	44.0	63.3	19.2	17.2	0.08
Sexual dysfunction	47	22.3	23	21.9	24	22.6	0.90	89.0	93.7	88.5	70.0	0.98
Fatigue	46	21.8	22	21	24	22.6	0.77	49.1	55.2	31.4	32.5	0.22
Insomnia	45	21.3	20	19	25	23.6	0.42	71.5	116.4	37.2	37.3	0.20
Dry mouth	41	19.4	16	15.2	25	23.6	0.13	54.4	62.9	72.3	73.4	0.43
Dizziness	33	15.6	16	15.2	17	16	0.87	38.9	78.4	10.3	11.4	0.19
Diarrhea	32	15.2	15	14.3	17	16	0.72	21.0	34.6	13.4	22.3	0.48
Constipation	20	9.5	8	7.6	12	11.3	0.36	24.6	30.0	27.2	22.6	0.83
Anxiety	18	8.5	8	7.6	10	9.4	0.64	15.8	18.3	15.4	16.9	0.97
Abdominal pain	17	8.1	6	5.7	11	10.4	0.21	12.6	15.1	9.6	9.6	0.64
Yawning	16	7.6	7	6.7	9	8.5	0.62	31.6	16.5	45.0	59.9	0.58
Appetite decreased	16	7.6	7	6.7	9	8.5	0.62	20.2	15.6	50.0	53.2	0.22
Emotional blunting	15	7.1	11	10.5	4	3.8	0.06	38.0	24.4	24.8	24.8	0.38
Dyspepsia	14	6.6	6	5.7	8	7.5	0.59	33.8	42.1	13.8	11.8	0.34
Bruxism	14	6.6	8	7.6	6	5.7	0.57	88.6	85.6	54.0	41.6	0.38
Sweating increased	13	6.2	4	3.8	9	8.5	0.16	41.3	23.4	41.3	37.1	0.99
Jitteriness	12	5.7	6	5.7	6	5.7	0.99	10.3	5.1	5.8	5.9	0.28
Restlessness	11	5.2	5	4.8	6	5.7	0.77	18.3	24.5	19.3	14.7	0.95